Study Identifies Anxious Depressive Attacks Across Diverse Psychiatric Disorders in Specialty Clinic

A psychiatric investigation conducted at a specialized anxiety clinic in Tokyo has revealed that anxious depressive attacks represent a highly prevalent and clinically complex symptom pattern affecting more than one-fifth of newly presenting psychiatric outpatients. The condition, characterized as a distinct cognitive variant of the conventional panic attack, involves sudden eruptions of acute emotional distress accompanied immediately by severe, intrusive ruminations rather than the prominent autonomic sensations that define standard panic episodes. Researchers documented a lifetime prevalence of 21.68 percent among evaluated clinic patients, demonstrating that these acute cognitive surges occur across a wide variety of categorical psychiatric diagnoses. Rather than functioning as an isolated diagnostic category, the attacks appear to operate as an overarching transdiagnostic phenomenon that is closely tied to heightened interpersonal vulnerability and elevated overall clinical severity in outpatient psychiatric care.

The concept of the anxious depressive attack draws direct historical inspiration from early psychoanalytic observations documented by Sigmund Freud in his 1895 work on separating anxiety neurosis from broader nervous breakdowns. Freud originally posited that anxiety attacks could manifest in three distinct forms: pure affective anxiety without conscious ideas, anxiety accompanied by somatic and physiological disturbances, or anxiety paired directly with catastrophic cognitive interpretations. Contemporary psychiatry codified the somatic variety into the diagnostic criteria for panic attacks, while the cognitive presentation received substantially less systematic research attention. In modern clinical practice, individuals experiencing an anxious depressive attack undergo an abrupt onset of intense negative affect—including acute feelings of loneliness, agitation, and dread—which immediately triggers ruminative flashbacks centered around past regrets, perceived failures, or future catastrophes. Because of the overwhelming distress produced by these rapid ruminative cascades, some patients resort to impulsive and maladaptive behaviors, including non-suicidal self-injury or intentional medication overdoses, in an effort to cope with the surge.

To investigate the epidemiological frequency and psychological underpinnings of this presentation, investigators evaluated adult and adolescent patients who sought care at the Akasaka Clinic of the Warakukai Medical Corporation between July 2017 and December 2022. The patient population was selected from an initial pool of 4,767 first-time clinic attendees during this period. Eligible participants included individuals aged 16 to 79 years who provided informed consent to undergo the multi-stage diagnostic and psychological evaluation. Study protocols instituted explicit safety and methodological exclusion criteria, disqualifying individuals who exhibited severe suicide risk—defined as a score of 10 or greater on the Psychiatric Brief Structured Interview Suicide Risk Score—as well as those diagnosed with severe cognitive impairment or unstable physical complications. Following the initial screening, 343 patients consented, after which 54 cases with incomplete data records and three individuals outside the valid age parameters were removed, yielding a final analytical sample of 286 patients.

The clinical assessment protocol utilized standardized structured interviews administered independently by a qualified psychiatrist and Japanese certified public psychologists. Axis I psychiatric disorders were systematically established using the Japanese edition of the Mini-International Neuropsychiatric Interview, while Axis II personality disorders were assessed using the Structured Clinical Interview for DSM-IV Axis II Personality Disorders. Neurodevelopmental conditions, specifically autism spectrum disorder and attention-deficit/hyperactivity disorder, were evaluated according to diagnostic criteria from the DSM-5-TR desk reference. The presence of anxious depressive attacks was adjudicated using operationalized criteria that required independent agreement between the physician and psychologists; cases demonstrating diagnostic disagreement were excluded from final prevalence classifications to preserve internal diagnostic validity. The inter-rater agreement between the diagnostic assessors yielded a Cohen’s kappa coefficient of 0.32, reflecting a modest but consistent degree of concordance for this newly operationalized clinical entity.

The research battery incorporated an extensive series of self-administered and clinician-rated psychological measures to capture diverse dimensions of psychopathology and developmental history. Childhood experiences were evaluated using a self-administered Past History Questionnaire that systematically cataloged experiences of abuse and early parental separation occurring prior to age 15. Depressive severity was quantified using both the clinician-administered 17-item Hamilton Depression Rating Scale and the 16-item self-reported Quick Inventory of Depressive Symptoms. Anxiety and social distress were measured using the 14-item Hamilton Anxiety Rating Scale and the 24-situation Liebowitz Social Anxiety Scale. In addition, neurodevelopmental tendencies were screened using the Autism Questionnaire Japanese version with a diagnostic threshold of 33, and the adult Attention-Deficit/Hyperactivity Disorder Self-Rating Scale version 1.1. Interpersonal vulnerability was captured via the 40-item Interpersonal Stress Event Scale—measuring conflict, inferiority, and exhaustion—and the 27-item Interpersonal Sensitivity Measure, which assesses rejection sensitivity across five distinct sub-factors.

Demographic analyses demonstrated significant differences between patients with and without a documented history of anxious depressive attacks. Patients exhibiting these attacks were significantly younger at presentation, with a mean age of 31.18 years compared to 38.83 years in the non-attack cohort, a divergence that proved highly statistically significant. The reported age of onset for anxious depressive attacks ranged widely from early childhood at 6 years to middle adulthood at 44 years, with a collective mean onset of 21.1 years and a median of 20 years. While female patients reported an earlier average onset age of 19.7 years compared to 25.7 years among male participants, this specific sex difference did not attain statistical significance. Notably, the study revealed an average latency of 95.1 months—amounting to approximately eight years—between the initial emergence of attacks and the patient’s first clinical consultation at the specialty clinic, highlighting prolonged periods of unaddressed symptoms.

Epidemiological calculations within the specialty clinic sample established that 62 of the 286 patients met the diagnostic criteria for a lifetime history of anxious depressive attacks, corresponding to a lifetime prevalence rate of 21.68 percent. Among this group, 46 individuals—consisting of 35 women and 11 men—had suffered an episode within the two weeks immediately preceding the clinical evaluation, establishing a current prevalence rate of 16.08 percent. The remaining 16 patients had experienced episodes prior to the two-week threshold. When examining comorbid panic disorder, lifetime rates were 39.98 percent in the attack cohort and 38.85 percent in the comparison cohort, while current panic disorder stood at 25.42 percent and 21.14 percent, respectively. The investigators noted that the observed 21.68 percent lifetime prevalence of anxious depressive attacks closely mirrors the 22.7 percent lifetime prevalence of somatic panic attacks previously reported in large-scale general epidemiological surveys in the United States.

Analysis of diagnostic distributions revealed marked psychiatric comorbidity, with attacks identified across 14 discrete Axis I disorders, six Axis II personality disorders, and both evaluated neurodevelopmental conditions. Patients suffering from anxious depressive attacks exhibited an average of 3.5 concurrent diagnoses on the Mini-International Neuropsychiatric Interview, compared to an average of only 1.5 diagnoses among patients without attacks, representing a pronounced difference with a large effect size. Furthermore, co-occurring mood and anxiety disorders were substantially more prevalent in the attack cohort, where 55.9 percent presented with simultaneous affective and anxiety disorders compared to 13.7 percent of the comparison group. Developmental screening demonstrated that positive screening tendencies for attention-deficit/hyperactivity disorder were present in 45.8 percent of attack patients versus 12.6 percent of controls, while autism tendencies appeared in 13.6 percent compared to 4.6 percent. Self-reported histories of childhood abuse were likewise significantly more common among attack patients, at 37.3 percent versus 19.8 percent.

Psychological battery scores across all evaluated dimensions—including general anxiety, objective and subjective depression, social phobia, interpersonal stress, and rejection sensitivity—were significantly higher among individuals with anxious depressive attacks than among their unaffected peers. Patients experiencing current episodes scored higher than those with past episodes on nearly all diagnostic metrics, although social anxiety, interpersonal stress, and rejection sensitivity remained elevated across both subgroups. To evaluate how these psychological factors interact, the authors performed structural equation modeling using robust maximum likelihood estimation on a sub-sample of 202 patients who had complete psychological profiles, comprising 33 current attack cases and 169 non-attack cases. The structural equation model demonstrated that rejection sensitivity exerted significant direct positive paths toward generalized anxiety and social anxiety scores, while having no direct path to depression scores. Crucially, anxious depressive attacks were found to be independently and directly predicted by both clinician-rated depressive symptoms and interpersonal rejection sensitivity.

Sensitivity analyses employing the weighted least squares mean- and variance-adjusted estimator confirmed robust structural equation model fit indices, yielding a chi-square of 2.671 with two degrees of freedom, a comparative fit index of 0.997, a Tucker-Lewis index of 0.985, a root mean square error of approximation of 0.041, and a standardized root mean square residual of 0.016. In their discussion of differential diagnosis, the researchers distinguished the condition from several classical psychiatric presentations. Unlike panic attacks, anxious depressive attacks lack prominent cardiovascular and respiratory sensations, autonomic surges, and anticipatory anxiety. Although sharing clinical severity markers with major depressive disorder accompanied by anxious distress, anxious depressive episodes take the form of discrete, sudden cognitive cascades rather than persistent tension. They likewise diverge from ICD-11 mixed depressive and anxiety disorder, which entails chronic subthreshold symptoms, as well as dissociative disorders, post-traumatic stress disorder, and focal temporal lobe seizures.

The study contextualized its clinical observations within historical medical literature, noting that prior Western reports had largely overlooked the syndrome aside from Donald Klein and Michael Liebowitz’s description of hysteroid dysphoria—a condition marked by abrupt depressive crashes following perceived rejection that shares substantial overlap with modern atypical depression. Previous clinic data indicated that atypical depression demonstrated the highest rate of anxious depressive attacks at 78.3 percent. The authors hypothesized that several structural factors have historically obscured recognition of these attacks: internal ruminative states are inherently less visible to clinicians than physical hyperventilation or trembling; episodes are subjectively distressing yet ego-syntonic during the surge; and episodes typically persist longer than panic attacks, lasting from several minutes to an entire day, with an average duration of approximately two hours.

The investigators emphasized important methodological limitations, noting that because the data were gathered exclusively from first-time visitors at a specialized outpatient anxiety clinic, the 21.68 percent prevalence figure cannot be directly generalized to the general population or unspecialized community settings. Additionally, the structural equation model was constrained by a modest sample size of 202 individuals, containing only 33 active attack cases, which introduces potential risks of model overfitting and underscores the necessity of replication across larger, multi-center cohorts. Nevertheless, the research team concluded that anxious depressive attacks represent a clinically meaningful, transdiagnostic syndrome fundamentally mediated by depressive severity and rejection sensitivity. Systematically screening for these acute cognitive episodes during psychiatric intakes could help clinicians identify high-risk, treatment-resistant patients earlier and tailor interventions to address underlying interpersonal vulnerabilities.

Subject of Research: Prevalence and clinical characteristics of anxious depressive attacks in psychiatric outpatients

Article Title: Anxious Depressive Attack (ADA) -its prevalence and clinical implication

Article References: Kaiya, H., Noda, S., Matsumoto, S., Sakai, Y., Otowa, T., Sasaki, T., & Minami, F. (2026). Anxious Depressive Attack (ADA) -its prevalence and clinical implication. BioPsychoSocial Medicine, 20(1), Article 9. https://doi.org/10.1186/s13030-026-00355-1

Image Credits: AI Generated

DOI: 10.1186/s13030-026-00355-1

Keywords: Anxious Depressive Attack, Panic Attacks, Rejection Sensitivity, Psychiatric Comorbidity, Depression, Anxiety Disorders, Structural Equation Modeling, Atypical Depression, Anxious, Depressive, Attack, prevalence